Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT07081074
Recruiting
ROS-scavenging Amino Acid-derived Lipids for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer
Not applicable · China · 1 site
Registry update: 15 Apr 2026
NCT07024173
Recruiting
A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer
Phase 3 · China · 2 sites
Registry update: 2 Oct 2026
NCT07072624
Recruiting
Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial)
Phase 4 · India · 3 sites
Registry update: 29 Oct 2026
NCT07313904
Recruiting
Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and Bronchiectasis
Not applicable · China · 1 site
Registry update: 2 Jan 2026
NCT07113223
Recruiting
Determining Efficacy of an Artificial Intelligence-based System for Heart Failure Detection Through Interpretation of Electrocardiograms (DECISION)
Not applicable · Spain, Sweden · 5 sites
Registry update: 4 Nov 2026
NCT06909565
Recruiting
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Phase 4 · United States · 149 sites
Registry update: 29 Oct 2026
NCT07065344
Recruiting
A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region
Not applicable · United Arab Emirates, Egypt, Iraq, Jordan, Kuwait, Morocco, Oman, Qatar, Saudi Arabia · 20 sites
Registry update: 23 Sept 2026
NCT07165847
Recruiting
Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)
Phase 2 · China · 1 site
Registry update: 10 Sept 2025
NCT06315257
Recruiting
A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients
Phase 1 · United States · 2 sites
Registry update: 1 Jul 2026
NCT06967961
Recruiting
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
Not applicable · France · 1 site
Registry update: 15 Jun 2026
NCT06828822
Recruiting
CongenItal Naevus Cohort for Longitudinal Evaluation
Not applicable · France · 16 sites
Registry update: 24 Sept 2026
NCT07751380
Recruiting
Multi-modular Chimeric Antigen Receptor T Cells tarGeting B7-H3 in Children, Teenage & Young Adult Sarcoma
Phase 1 · United Kingdom · 2 sites
Registry update: 7 Aug 2026
NCT06753136
Recruiting
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
Not applicable · Italy · 1 site
Registry update: 13 Apr 2026
NCT07270679
Recruiting
Genetic Markers of Susceptibility to Chemotherapy-induced Ovarian Damage in Cancer Patients Undergoing Ovarian Biopsy for Cryopreservation.
Not applicable · Italy · 1 site
Registry update: 8 Dec 2025
NCT06953960
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Phase 1/2 · Australia, Belgium, Germany, France, United Kingdom, Israel, Italy, Japan, Poland, Portugal, Sweden, United States · 56 sites
Registry update: 27 Oct 2026
NCT06940388
Recruiting
Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.
Phase 2 · Germany, Israel · 6 sites
Registry update: 24 Jul 2025
NCT06674785
Recruiting
SIRS-ESWT Trial: Shoulder Internal Rotator Spasticity Trial Treated With Extracorporeal Shock Wave Therapy Trial
Not applicable · Taiwan · 1 site
Registry update: 29 Jul 2025
NCT06911632
Recruiting
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Not applicable · United States · 41 sites
Registry update: 3 Nov 2026
NCT06950983
Recruiting
Navigating Financial and Health-Related Social Needs in Adolescent and Young Adult Cancer Survivors (AYA-NAV)
Not applicable · United States · 1 site
Registry update: 23 Jul 2026
NCT06758401
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Phase 3 · Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Canada, Switzerland, Chile, China, Czechia, Germany, Denmark, Spain, France, United Kingdom, Greece, Hungary, Israel, India, Italy, Japan, South Korea, Mexico, Netherlands, Poland, Romania, Saudi Arabia, Slovakia, Taiwan, United States · 385 sites
Registry update: 25 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.